HSPB1 and cancer: Therefore, targeting Hsp27, Hsp60, Hsp70, or Hsp90 with CRISPR/Cas9 to enhance the selectivity for target Hsps, and combining different Hsps inhibitors, could be promising strategies to improve the effectiveness of cancer therapy.